Semi-high-throughput screening platform for 5 alpha-reductase inhibitors
A screening platform using radio-labeled substrates and HPLC to identify inhibitors of 5 alpha-reductase enzymes (SRD5A1 and SRD5A2). Supports drug discovery for conditions such as benign prostatic hyperplasia, androgene...